{
  "trial_id": "NCT01484626",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adults with relapsed and/or refractory myeloma",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Must have adequate liver function",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Zubrod Performance Status (ZPS) of 2 or better",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Must have measurable disease",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Peripheral neuropathy of grade II or higher",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Thrombocytopenia (platelets less than 50,000/uL)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has relapsed and refractory myeloma with adequate liver function and Zubrod Performance Status of 2 or better. However, thrombocytopenia is not mentioned in the patient's history.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT01484626",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}